Human intestinal organoids represent a novel model for assessing the effects of immunosuppressants on rotavirus infection.
Mycophenolic acid potently inhibits rotavirus via depleting intracellular guanosine nucleotides.
Mycophenolic acid has a high barrier to drug resistance development.